Nod-like Receptors: Key Molecular Switches in the Conundrum of Cancer

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2014 May 6

PMID 24795727

Citations 15

Authors

Andrew Kent

J Magarian Blander

Affiliations

Soon will be listed here.

Abstract

It is believed the immune system can contribute to oncogenic transformation especially in settings of chronic inflammation, be activated during immunosurveillance to destroy early neoplastic cells before they undergo malignant outgrowth, and finally, can assist growth of established tumors by preventing clearance, remodeling surrounding tissue, and promoting metastatic events. These seemingly opposing roles of the immune system at the different stages of cancer development must all be mediated by innate signaling mechanisms that regulate the overall state of immune activation. Recently, the cytosolic nod-like receptor (NLR) pathway of innate immunity has gained a lot of attention in the tumor immunology field due to its known involvement in promoting inflammation and immunity, and conversely, in regulating tissue repair processes. In this review, we present all the current evidence for NLR involvement in the different stages of neoplasia to understand how a single molecular pathway can contribute to conflicting immunological interactions with cancer.

Citing Articles

A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesis.

Kent A, Yee Mon K, Hutchins Z, Putzel G, Zhigarev D, Grier A Nat Immunol. 2025; 26(1):53-67.

PMID: 39747433 DOI: 10.1038/s41590-024-02028-z.

Role of N6-methyladenosine methylation in head and neck cancer and its regulation of innate immune pathways.

Cao L, Huang G, Fan J, Liu X, Ma Z Front Immunol. 2024; 15:1458884.

PMID: 39403369 PMC: 11471572. DOI: 10.3389/fimmu.2024.1458884.

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma.

Zhou G, Qin G, Zhang Z, Zhao H, Xue L Front Immunol. 2023; 14:1283792.

PMID: 37954600 PMC: 10637370. DOI: 10.3389/fimmu.2023.1283792.

Immunotoxicity and Transcriptome Analyses of Zebrafish () Embryos Exposed to 6:2 FTSA.

Zhang J, Ren Z, Chen M Toxics. 2023; 11(5).

PMID: 37235273 PMC: 10222677. DOI: 10.3390/toxics11050459.

Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.

Pansy K, Uhl B, Krstic J, Szmyra M, Fechter K, Santiso A Int J Mol Sci. 2021; 22(24).

PMID: 34948104 PMC: 8706102. DOI: 10.3390/ijms222413311.

References

Fantuzzi G, Mendoza L, Fuentes A, Anasagasti M, Martin J, Carrascal T . IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A. 2000; 97(2):734-9. PMC: 15399. DOI: 10.1073/pnas.97.2.734. View

Zitvogel L, Kepp O, Galluzzi L, Kroemer G . Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol. 2012; 13(4):343-51. DOI: 10.1038/ni.2224. View

Drexler S, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H . Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci U S A. 2012; 109(45):18384-9. PMC: 3494892. DOI: 10.1073/pnas.1209171109. View

Dvorak H . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650-9. DOI: 10.1056/NEJM198612253152606. View

Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N . IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res. 2011; 71(16):5393-9. DOI: 10.1158/0008-5472.CAN-11-0993. View

Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi M, Mantovani A . Molecular pathways in cancer-related inflammation. Biochem Med (Zagreb). 2012; 21(3):264-75. DOI: 10.11613/bm.2011.036. View

Allen I, Wilson J, Schneider M, Lich J, Roberts R, Arthur J . NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity. 2012; 36(5):742-54. PMC: 3658309. DOI: 10.1016/j.immuni.2012.03.012. View

Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F . Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med. 2012; 19(1):57-64. DOI: 10.1038/nm.2999. View

Zaki M, Vogel P, Malireddi R, Body-Malapel M, Anand P, Bertin J . The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011; 20(5):649-60. PMC: 3761879. DOI: 10.1016/j.ccr.2011.10.022. View

10.

Zheng J, Pei D, Mao L, Liu X, Sun F, Zhang B . Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis. Cancer Gene Ther. 2009; 17(1):28-36. DOI: 10.1038/cgt.2009.38. View

11.

Hashimoto W, Tanaka F, Robbins P, Taniguchi M, Okamura H, Lotze M . Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18. Int J Cancer. 2002; 103(4):508-13. DOI: 10.1002/ijc.10844. View

12.

Negash A, Ramos H, Crochet N, Lau D, Doehle B, Papic N . IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 2013; 9(4):e1003330. PMC: 3635973. DOI: 10.1371/journal.ppat.1003330. View

13.

Bui J, Schreiber R . Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?. Curr Opin Immunol. 2007; 19(2):203-8. DOI: 10.1016/j.coi.2007.02.001. View

14.

Tyler D, FRANCIS G, Frederick M, Tran A, Ordonez N, Smith J . Interleukin-1 production in tumor cells of human melanoma surgical specimens. J Interferon Cytokine Res. 1995; 15(4):331-40. DOI: 10.1089/jir.1995.15.331. View

15.

Cho D, Song H, Kim Y, Houh D, Hur D, Park H . Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res. 2000; 60(10):2703-9. View

16.

Schafer M, Werner S . Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol. 2008; 9(8):628-38. DOI: 10.1038/nrm2455. View

17.

Knowles H, Leek R, Harris A . Macrophage infiltration and angiogenesis in human malignancy. Novartis Found Symp. 2004; 256:189-200. View

18.

Hu B, Elinav E, Flavell R . Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation. Cell Cycle. 2011; 10(12):1936-9. DOI: 10.4161/cc.10.12.16008. View

19.

Okamoto M, Liu W, Luo Y, Tanaka A, Cai X, Norris D . Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem. 2009; 285(9):6477-88. PMC: 2825443. DOI: 10.1074/jbc.M109.064907. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View